Medical Publications – 2023

  • Michoud, C ; Erard, D ; Valette, PJ ; Bertrand, G ; Ponchon, T ; Milot, L & al. A biliary cast syndrome requiring liver transplantation: an original sequence. J Gastrointestin Liver Dis. 2023;32:565-566
  • Perrier, M ; Brugel, M ; Gérard, L ; Goichot, B ; Lièvre, A ; Lepage, C & al. Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network. Eur J Endocrinol. 2023;189:575-583
  • Eiseler, K ; Neppl, L ; Schmidt, AW ; Rauscher, B ; Ewers, M ; Masson, E & al. Genetic and functional analysis of chymotrypsin-like protease (CTRL) in chronic pancreatitis. Pancreatology. 2023;23:957-963
  • Kos-Kudła, B ; Castaño, JP ; Denecke, T ; Grande, E ; Kjaer, A ; Koumarianou, A & al. European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours. J Neuroendocrinol. 2023;35:e13343
  • Ronot, M ; Dioguardi Burgio, M ; Gregory, J ; Hentic, O ; Vullierme, MP ; Ruszniewski, P & al. Appropriate use of morphological imaging for assessing treatment response and disease progression of neuroendocrine tumors. Best Pract Res Clin Endocrinol Metab. 2023;37:101827
  • Kalifi, M ; Deguelte, S ; Faron, M ; Afchain, P ; de Mestier, L ; Lecomte, T & al. The Need for Centralization for Small Intestinal Neuroendocrine Tumor Surgery: A Cohort Study from the GTE-Endocan-RENATEN Network, the CentralChirSINET Study. Ann Surg Oncol. 2023;30:8528-8541
  • Aguilera Munoz, L ; Boros, C ; Bonvalet, F ; Ronot, M ; Rebours, V. Pancreatic Acinar Cystic Transformation: Familial Forms Do Exist. Pancreas. 2023;52:e210-e212
  • Freedman, S ; de-Madaria, E ; Bruckert, E ; Löhr, M ; Rebours, V ; Jandhyala, R. A protocol for an international, multicenter, prospective, non-interventional observational registry for patients with hypertriglyceridemia. Curr Med Res Opin. 2023;39:1663-1670
  • De Rycke, O ; Perrier, M ; Ouvrard, É ; Mennetrey, C ; Lachachi, C ; Bando-Delaunay, A & al. High Tumor Uptake on  <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d”étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network. J Nucl Med. 2023;64:1699-1705
  • Masson, E ; Zou, WB ; Pu, N ; Rebours, V ; Génin, E ; Wu, H & al. Classification of PRSS1 variants responsible for chronic pancreatitis: An expert perspective from the Franco-Chinese GREPAN study group. Pancreatology. 2023;23:491-506
  • Hofland, J ; Falconi, M ; Christ, E ; Castaño, JP ; Faggiano, A ; Lamarca, A & al. European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes. J Neuroendocrinol. 2023;35:e13318
  • Suc, G ; Cachier, A ; Hentic, O ; Bazire, B ; Sannier, A ; Delhomme, C & al. Management and outcomes of carcinoid heart disease with liver metastases of midgut neuroendocrine tumours. Heart. 2023;110:132-139
  • Freedman, S ; de-Madaria, E ; Bruckert, E ; Löhr, M ; Rebours, V ; Jandhyala, R. Observed consensus on research priorities for the hypertriglyceridemia patient registry. Curr Med Res Opin. 2023;39:1629-1635
  • Becq, A ; Szewczyk, J ; Salin, G ; Chartier, M ; Chaput, U ; Leenhardt, R & al. ERCP 2.0: Biliary 3D-reconstruction in patients with malignant hilar stricture. Clin Res Hepatol Gastroenterol. 2023;47:102172
  • de Mestier, L ; Resche-Rigon, M ; Dromain, C ; Lamarca, A ; La Salvia, A ; de Baker, L & al. Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST. J Neuroendocrinol. 2023;35:e13311
  • Bourdeleau, P ; Couvelard, A ; Ronot, M ; Lebtahi, R ; Hentic, O ; Ruszniewski, P & al. Spatial and temporal heterogeneity of digestive neuroendocrine neoplasms. Ther Adv Med Oncol. 2023;15:17588359231179300
  • Hedjoudje, A ; Cheurfa, C ; Talby, ME ; Levy, P ; Prat, F ; Piton, G. Author”s Reply: “Delayed ERCP in the setting of severe acute cholangitis – How much delay is “Delayed””?””. Dig Liver Dis. 2023;55:1149
  • Saillard, C ; Delecourt, F ; Schmauch, B ; Moindrot, O ; Svrcek, M ; Bardier-Dupas, A & al. Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma. Nat Commun. 2023;14:3459
  • Masson, E ; Berthet, S ; Le Gac, G ; Le Rhun, M ; Ka, C ; Autret, S & al. Identification of protease-sensitive but not misfolding PNLIP variants in familial and hereditary pancreatitis. Pancreatology. 2023;23:507-511
  • Alexandra, JF ; Roux, D ; Maisonneuve, H ; Chousterman, B ; Ruszniewski, P ; Dreyfuss, D. Toward improvement of knowledge of financial conflicts of interest in a large medical school in France. PLoS One. 2023;18:e0285894
  • Hernando, J ; Roca-Herrera, M ; García-Álvarez, A ; Raymond, E ; Ruszniewski, P ; Kulke, MH & al. Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours. Eur J Cancer. 2023;188:39-48
  • Previtali, C ; Sartoris, R ; Rebours, V ; Couvelard, A ; Cros, J ; Sauvanet, A & al. Quantitative imaging predicts pancreatic fatty infiltration on routine CT examination. Diagn Interv Imaging. 2023;104:359-367
  • Chaigneau, T ; Aguilera Munoz, L ; Oger, C ; Gourdeau, C ; Hentic, O ; Laurent, L & al. Efficacy and tolerance of LV5FU2-carboplatin chemotherapy in patients with advanced pancreatic ductal adenocarcinoma after failure of standard regimens. Ther Adv Med Oncol. 2023;15:17588359231163800
  • Delhomme, C ; Walter, T ; Arangalage, D ; Suc, G ; Hentic, O ; Cachier, A & al. Carcinoid heart disease in patients with midgut neuroendocrine tumours. J Neuroendocrinol. 2023;35:e13262
  • Michoud, C ; Khoury, T ; Lisotti, A ; Gincul, R ; Leblanc, S ; Lemaistre, AI & al. Needle-based confocal laser endomicroscopy for cystic lymphangiomas of the pancreas: the first case series. Endoscopy. 2023;55:E594-E595
  • Mas, L ; Cros, J ; Svrcek, M ; Van Laethem, JL ; Emile, JF ; Rebours, V & al. Trop-2 is a ubiquitous and promising target in pancreatic adenocarcinoma. Clin Res Hepatol Gastroenterol. 2023;47:102108
  • Hedjoudje, A ; Cheurfa, C ; Et Talby, M ; Levy, P ; Prat, F ; Piton, G. Outcomes and predictors of delayed endoscopic biliary drainage for severe acute cholangitis due to choledocholithiasis in an intensive care unit. Dig Liver Dis. 2023;55:763-770
  • Robin, R ; Dokmak, S ; Rebours, V ; Ronot, M ; Lons, T ; de Mestier, L & al. [A very special cystic pancreatic neuroendocrine tumor]. Ann Pathol. 2023;43:475-478
  • Bouça-Machado, T ; Bouwense, SAW ; Brand, M ; Demir, IE ; Frøkjær, JB ; Garg, P & al. Position statement on the definition, incidence, diagnosis and outcome of acute on chronic pancreatitis. Pancreatology. 2023;23:143-150
  • Walter, T ; Lievre, A ; Coriat, R ; Malka, D ; Elhajbi, F ; Di Fiore, F & al. Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial. Lancet Oncol. 2023;24:297-306
  • Orozco-Gálvez, O ; Fernández-Codina, A ; Lanzillotta, M ; Ebbo, M ; Schleinitz, N ; Culver, EL & al. Development of an algorithm for IgG4-related disease management. Autoimmun Rev. 2023;22:103273
  • Tsopra, R ; Peiffer-Smadja, N ; Charlier, C ; Campeotto, F ; Lemogne, C ; Ruszniewski, P & al. Putting undergraduate medical students in AI-CDSS designers” shoes: An innovative teaching method to develop digital health critical thinking. Int J Med Inform. 2023;171:104980
  • Lugat, A ; Frampas, É ; Touchefeu, Y ; Mirallié, É ; Bras, ML ; Senellart, H & al. Prospective Multicentric Assessment of  <sup>68</sup>Ga-DOTANOC PET/CT in Grade 1-2 GEP-NET. Cancers (Basel). 2023;15:
  • Martin, A ; Cros, J ; Vullierme, MP ; Dokmak, S ; Sauvanet, A ; Levy, P & al. Dilatation of the main pancreatic duct of unknown origin: causes and risk factors of pre-malignancy or malignancy. Surg Endosc. 2023;37:3684-3690
  • Noureddine, S ; Roux-Claudé, P ; Laurent, L ; Ritter, O ; Dolla, P ; Karaer, S & al. Evaluation of long-term sequelae by cardiopulmonary exercise testing 12&nbsp;months after hospitalization for severe COVID-19. BMC Pulm Med. 2023;23:13
  • Assouline, J ; Cannella, R ; Porrello, G ; de Mestier, L ; Dioguardi Burgio, M ; Raynaud, L & al. Volumetric Enhancing Tumor Burden at CT to Predict Survival Outcomes in Patients with Neuroendocrine Liver Metastases after Intra-arterial Treatment. Radiol Imaging Cancer. 2023;5:e220051
  • Lacombe, C ; Perrier, M ; Hentic, O ; Brixi, H ; De Rycke, O ; Cros, J & al. FOLFOX-bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors. J Neuroendocrinol. 2023;35:e13227
  • Auvray Kuentz, M ; Hautefeuille, V ; de Mestier, L ; Coutzac, C ; Lecomte, T ; Nardon, V & al. Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study. Int J Cancer. 2023;152:1894-1902
  • Masson, E ; Ewers, M ; Paliwal, S ; Kume, K ; Scotet, V ; Cooper, DN & al. The PRSS3P2 and TRY7 deletion copy number variant modifies risk for chronic pancreatitis. Pancreatology. 2023;23:48-56
  • Freedman, S ; de-Madaria, E ; Singh, VK ; Bruckert, E ; Löhr, M ; Sutton, R & al. A simple core dataset for triglyceride-induced acute pancreatitis. Curr Med Res Opin. 2023;39:37-46
  • Mamodaly, M ; Chen, R ; Deschamps, L ; de Mestier, L ; Couvelard, A ; Scoazec, JY & al. When it comes to chromogranin A, not all clones are made equal. Pathology. 2023;55:149-153